News for Aurinia Pharmaceuticals Inc. (AUPH)

On March 10, 2025, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a significant stock transaction involving Acelyrin Inc. The firm added 1,526,365 sha

On March 3, 2025, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a notable transaction by acquiring 5,859,044 shares of Pliant Therapeutics Inc (PLRX)

“The economy is strong overall and has made significant progress toward our goals over the past two years,” Federal Reserve Chair Jerome Powell said during a press conference Wednesday following the...

Significant Stock Acquisition by TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) On February 28, 2025, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed

On March 4, 2025, TANG KEVIN C (Trades, Portfolio), a recognized market expert, executed a significant stock transaction involving Aurinia Pharmaceuticals Inc (

Investors need to pay close attention to Aurinia Pharmaceuticals (AUPH) stock based on the movements in the options market lately.

Exploring the robust pipeline and market potential of Aurinia Pharmaceuticals Inc's flagship product, LUPKYNIS®.Assessing the impact of strategic restructurin

Total Revenue (Q4 2024): $59.9 million, up 33% from $45.1 million in Q4 2023.Total Revenue (Full Year 2024): $235.1 million, up 34% from $175.5 million in 2023

Feb 27, 2025 / 01:30PM GMTOperator Greetings and welcome to the Aurinia Pharmaceuticals fourth quarter and full year 2024 earnings call. (Operator Instructions)

On February 25, 2025, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a significant transaction by acquiring an additional 2,000,000 shares of Acelyrin

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ETCompany ParticipantsAndrea Christopher - Head,...

On February 13, 2025, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a significant stock transaction involving Cargo Therapeutics Inc (CRGX). The firm

On February 18, 2025, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a noteworthy transaction by acquiring 5,298,328 shares of Acelyrin Inc. This acqu

Aurinia Pharmaceuticals Inc (AUPH) has announced that it will release its financial and operational results for the fourth quarter and full year of 2024 before

Aurinia can still see growth in product revenues from Lupkynis and has a chance to show that AUR200 has some value in 2025. Learn more about AUPH stock now.

On February 7, 2025, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a significant transaction by acquiring 4,210,525 shares of Galapagos NV. This acqu

On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a notable transaction involving Aurinia Pharmaceuticals Inc (AUPH). The firm reduced i

On December 31, 2024, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a substantial reduction in its holdings of ITeos Therapeutics Inc (ITOS). The fir

Significant Transaction in Cybin Inc On December 31, 2024, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a notable transaction involving Cybin Inc, a